Novo Nordisk hires former Director General of DMA
![Photo: Stine Tidsvilde](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12818413.ece/ALTERNATES/schema-16_9/doc7eu74anw380emn50nu3.jpg)
When the now-former Director General of the Danish Medicines Agency (DMA) Thomas Senderovitz steps into his new role at Novo Nordisk in May, his main focus area will be clinical development, according to an email sent from Novo Nordisk to MedWatch.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.